KRAS and non-small cell lung carcinoma: In a prospective series of 365 patients with resected early stage NSCLC treated at Massachusetts General Hospital, K-RAS mutations were found only in smokers and were associated with worse survival (P = 0.009, log-rank test) only in stage I disease, but not in the whole population [30].